SCHEMBL19449335

SCHEMBL19449335

Nc1nnc(OCC2CCC2)s1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ GFER P55789 1/20 0.39
▸ MCHR1 Q99705 3/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ PARP15 Q460N3 1/20 0.35
▸ PARP10 Q53GL7 1/20 0.35
▸ PARP2 Q9UGN5 1/20 0.35
▸ CDK2 P24941 8/20 0.35
▸ CCNA2 P20248 6/20 0.35
▸ CCNA1 P78396 6/20 0.35
▸ CDK1 P06493 3/20 0.34
▸ CCNB1 P14635 3/20 0.34
▸ CCNB2 O95067 2/20 0.34
▸ CCNB3 Q8WWL7 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ MTOR P42345 1/20 0.34
▸ KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24501494 0.96 POLB (0.47) POLBGAAALDH1A1HPGDGFER
SCHEMBL22717781 0.94 POLB (0.40) POLBGAAALDH1A1HPGDGFER
SCHEMBL24501285 0.86 POLB (0.35) POLBGAAALDH1A1HPGDGFER
SCHEMBL24501049 0.85 DHFR (0.39) POLBGAAMCHR1SMN1; SMN2GLS
SCHEMBL24500857 0.83 POLB (0.35) POLBGAAALDH1A1HPGDGFER
SCHEMBL29108540 0.82 FEN1 (0.35) POLBGAAGLS
SCHEMBL24501232 0.82 KDM5A (0.33) POLBGAA
SCHEMBL24501428 0.81 POLB (0.33) POLBGAAMCHR1
SCHEMBL24500977 0.80 ALDH1A1 (0.35) POLBGAAALDH1A1HPGDGFER
SCHEMBL24501660 0.80 ALDH1A1 (0.35) POLBGAAALDH1A1HPGDGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170290815-A1 GLUTAMINASE INHIBITORS UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2017-10-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170290815-A1 GLUTAMINASE INHIBITORS GLUL, ASNS, GLS POLB 2882/4885GAA 142/4885ALDH1A1 959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback